(Q45384918)

14 December 2017

Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells (English)

1 reference

14 December 2017

1 reference

1 reference

3

1 reference

14 December 2017

James O'Beirne

1

0 references

author name string

Jon Mitchell

series ordinal

2

1 reference

PubMed ID

19409594

14 December 2017

Phillip M Harrison

series ordinal

4

1 reference

PubMed ID

19409594

14 December 2017

language of work or name

English

0 references

publication date

5 May 2009

1 reference

14 December 2017

1 reference

14 December 2017

389

1 reference

14 December 2017

1-2

1 reference

14 December 2017

1-7

1 reference

Differential dysfunction in dendritic cell subsets during chronic HCV infection.

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

HIV-1 down-regulates the expression of CD1d via Nef.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Antigen presentation and T cell stimulation by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

The MHC class I antigen presentation pathway: strategies for viral immune evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Major histocompatibility complex class-I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Proteomic profiling of cellular proteins interacting with the hepatitis C virus core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Differential subcellular localization of hepatitis C virus core gene products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

The C-terminal region of hepatitis C core protein is required for Fas-ligand independent apoptosis in Jurkat cells by facilitating Fas oligomerization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Dendritic cell susceptibility to hepatitis C virus genotype 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Dendritic cells: a link between innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Binding of hepatitis C virus to CD81

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Cell Surface Expression of Major Histocompatibility Complex Class I Molecules Is Reduced in Hepatitis C Virus Subgenomic Replicon-Expressing Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Identification of signal peptide peptidase, a presenilin-type aspartic protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Erythroid cell-specific mRNA stability elements in the alpha 2-globin 3' nontranslated region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

Biosynthesis and biochemical properties of the hepatitis C virus core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.03.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2009.03.035

1 reference

14 December 2017

1 reference

PubMed ID

19409594